Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens

Medical Oncology
Inês Margarida GomesCláudio Jorge Maia

Abstract

Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is overexpressed in numerous types of tumors, especially in prostate cancer. STEAP1 is located in the plasma membrane of epithelial cells and may play an important role in inter- and intracellular communication. Several studies suggest STEAP1 as a potential biomarker and an immunotherapeutic target for prostate cancer. However, the role of STEAP1 in cell proliferation and apoptosis remains unclear. Therefore, the role of STEAP1 in prostate cancer cells proliferation and apoptosis was determined by inducing STEAP1 gene knockdown in LNCaP cells. In addition, the effect of DHT on the proliferation of LNCaP cells knocked down for STEAP1 gene was evaluated. Our results demonstrated that silencing the STEAP1 gene reduces LNCaP cell viability and proliferation, while inducing apoptosis. In addition, we showed that the cellular and molecular effects of STEAP1 gene knockdown may be independent of DHT treatment, and blocking STEAP1 may reveal to be an appropriate strategy to activate apoptosis in cancer cells, as well as to prevent the proliferative and anti-apoptotic effects of DHT in prostate cancer.

References

Nov 17, 1998·The Journal of Urology·A M De MarzoD S Coffey
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·R S HubertD E Afar
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Oct 5, 2001·The Journal of Allergy and Clinical Immunology·K C Zimmermann, D R Green
Dec 31, 2002·Toxicology·J A Pietenpol, Z A Stewart
Apr 20, 2006·Cancer Immunology, Immunotherapy : CII·Pedro M S AlvesKostas Kosmatopoulos
Sep 17, 2008·Cancer Letters·M T ValentiV Lo Cascio
Feb 26, 2009·Cell·Richard W Carthew, Erik J Sontheimer
May 15, 2009·Nature Reviews. Cancer·Tarek Abbas, Anindya Dutta
Nov 17, 2009·Journal of Endocrinological Investigation·M T ValentiL Dalle Carbonare
Jul 29, 2011·Methods in Molecular Biology·Diping Wang, Donald J Tindall
Nov 15, 2011·Molecular Cancer Research : MCR·Thomas G P GrunewaldStefan Burdach
Feb 10, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T G P GrunewaldS Burdach
Apr 24, 2012·Molecular Cancer Research : MCR·Inês M GomesCecília R Santos
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
May 4, 2017·Current Cancer Drug Targets·J Barroca-FerreiraC J Maia
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T G P GrunewaldS Burdach

❮ Previous
Next ❯

Citations

Aug 18, 2020·BioMed Research International·Hua-Tao WuJing Liu
Dec 9, 2020·Cancers·Amirhossein Bahreyni, Honglin Luo
Feb 10, 2021·International Journal of Molecular Sciences·Matteo RoselliniFrancesco Massari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.